您的购物车当前为空
别名 阿奈利普隆, GSBR-1290, GSBR1290
Aleniglipron(GSBR-1290)是一种具有口服活性和非肽的GLP-1激动剂,与跨膜结构域(TM1,TM2和TM7)内的深层正畸腔结合,能够减轻体重和改善胰岛素敏感性,可用于研究肥胖。


为众多的药物研发团队赋能,
让新药发现更简单!
Aleniglipron(GSBR-1290)是一种具有口服活性和非肽的GLP-1激动剂,与跨膜结构域(TM1,TM2和TM7)内的深层正畸腔结合,能够减轻体重和改善胰岛素敏感性,可用于研究肥胖。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,480 | In Stock | |
| 5 mg | ¥ 5,860 | In Stock | |
| 10 mg | ¥ 7,890 | In Stock | |
| 25 mg | ¥ 11,700 | In Stock | |
| 50 mg | ¥ 15,800 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 9,830 | In Stock |
Aleniglipron 相关产品
| 产品描述 | Aleniglipron (GSBR-1290) is an orally active, non-peptide GLP-1 agonist that binds to deep orthosteric pockets within transmembrane domains (TM1, TM2, and TM7). It reduces body weight and improves insulin sensitivity, making it suitable for obesity research. |
| 别名 | 阿奈利普隆, GSBR-1290, GSBR1290 |
| 分子量 | 915.99 |
| 分子式 | C49H55FN9O6P |
| CAS No. | 2685823-26-9 |
| Smiles | C[C@@H]1[C@](C1)(N2C=3C(C=C2C(=O)N4[C@@H](C)C5=C(N(N=C5CC4)C6=CC(C)=C(F)C(C)=C6)N7C(=O)N(C=C7)C8=CC(NC)=C(P(CC)(CC)=O)C=C8)=CC(=CC3)C9CCOCC9)C%10=NOC(=O)N%10 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (87.34 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容